Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery
Authors:
- Kristine EitingKEKristine Eiting
- Kunyuan CuiKCKunyuan Cui
- Alexis Kays LeonardALAlexis Kays Leonard
- Daniel MorrisDMDaniel Morris
- Ching-Yuan LiCLChing-Yuan Li
- Ken FarberKFKen Farber
- Anthony P. SilenoASAnthony P. Sileno
- Michael E. HoustonMHMichael E. Houston
- Paul H. JohnsonPJPaul H. Johnson
- Steven C. QuaySQSteven C. Quay
- Henry R. CostantinoHCHenry R. Costantino
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 95 (6) , 1364-1371
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Mucosal Drug Delivery: Membranes, Methodologies, and ApplicationsCritical Reviews™ in Therapeutic Drug Carrier Systems, 2004
- Nasal drug delivery—possibilities, problems and solutionsJournal of Controlled Release, 2003
- Absorption Enhancers for Nasal Drug DeliveryClinical Pharmacokinetics, 2003
- Permeability issues in nasal drug deliveryDrug Discovery Today, 2002
- Peptide hormones: Review of current and emerging uses by nasal deliveryAdvanced Drug Delivery Reviews, 1998
- Optimization of systemic nasal drug delivery with pharmaceutical excipientsAdvanced Drug Delivery Reviews, 1998
- Intranasal drug deliveryAdvanced Drug Delivery Reviews, 1998
- Effect of Formulation Additives upon the Intranasal Bioavailability of a Peptide Drug: Tetracosactide (ACTH1−24)Pharmaceutical Research, 1994
- The Molecular Weight Dependence of Nasal Absorption: The Effect of Absorption EnhancersPharmaceutical Research, 1990
- Site Dependence of Absorption-Promoting Actions of Laureth-9, Na Salicylate, Na2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin DeliveryPharmaceutical Research, 1988